| J1602 | Injection, golimumab, 1 mg, for intravenous use | 53,700 | $10 | $537K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,550 | $30 | $392.7K |
| J0897 | Injection, denosumab, 1 mg | 12,120 | $20 | $218.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,110 | $30 | $184.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,080 | $80 | $170.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 580 | $90 | $52.4K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 130 | $120 | $15.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 260 | $60 | $14.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 100 | $110 | $11.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 250 | $50 | $11.1K |